In conclusion, we observed that PATZ1 expression and subcellular localization are regulated in NSCLC, where high expression and nuclear localization are associated with the LUSC subtype, low tumor PD-L1 expression, and, at least for gene expression, better survival, suggesting that it could be used as a diagnostic and prognostic biomarker of this disease. Here, PATZ1 is linked to neoplasm.